XOMA Stock - XOMA Ltd

XOMA Stock Chart

XOMA Profile

XOMA Corporation operates as a biotechnology royalty aggregator across Europe, the United States, and the Asia Pacific, facilitating advancements in human health through strategic partnerships with biotech companies. The company specializes in acquiring future economic interests linked to pre-commercial therapeutic candidates licensed to pharmaceutical or biotechnology firms. XOMA primarily targets early to mid-stage clinical assets, focusing on those in Phase 1 and 2 trials that demonstrate potential for commercial success.

With a robust portfolio comprising approximately 70 assets, XOMA Corporation strategically positions itself to capitalize on emerging opportunities in the biopharmaceutical sector. By acquiring royalty rights from promising therapeutic developments, the company ensures a diversified revenue stream and contributes to the advancement of innovative treatments.

Founded in 1981 and headquartered in Emeryville, California, XOMA continues to expand its footprint in the biotechnology landscape. The company's enduring commitment to fostering collaborations and leveraging its expertise in royalty aggregation underscores its role in driving forward breakthrough therapies that address unmet medical needs.

XOMA Revenue Chart

XOMA Earnings

Analyst Ratings